May 23, 2017 9:20 PM ET


Company Overview of Chiesi USA, Inc.

Company Overview

Chiesi USA, Inc., a specialty pharmaceutical company, engages in the research, development, production, and commercialization of products in the areas of cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics to the healthcare community. Its products include CARDENE I.V., a nicardipine hydrochloride premixed injection; BETHKIS, a tobramycin inhalation solution; and CUROSURF, a poractant alfa intratracheal suspension solution. The company also provides PERTZYE, a pancrelipase delayed-release capsule; RETAVASE, a recombinant; ZYFLO, A zileuton tablet; and ZYFLO CR, a zileuton extended-release tablet. The company was formerly known as Cornerstone Therapeutics Inc....

1255 Crescent Green

Suite 250

Cary, NC 27518

United States

105 Employees



Key Executives for Chiesi USA, Inc.

Age: 51
Chief Financial Officer and Vice President of Finance
Principal Accounting Officer and Director of Accounting, Financial Planning & Analysis
Vice President of Clinical and Regulatory
Age: 53
Vice President of Strategy & Business Development
Age: 46
Compensation as of Fiscal Year 2016.

Chiesi USA, Inc. Key Developments

Chiesi USA, Inc. Announces Leadership Appointments

Chiesi USA announced the appointment of two key leadership roles as the company continues to focus on growth in the U.S. hospital and adjacent specialty product sector. Doug Baratta has been promoted to Vice President of Specialty and Corporate Accounts, and Donna White has been promoted to Vice President of Contracts and Compliance. In Baratta's expanded role, he is responsible for key customer-facing operations including Chiesi USA's relationships with wholesalers, specialty pharmacies, customer service and inside sales.

Chiesi Farmaceutici Eyes Acquisitions In US

Chiesi Farmaceutici S.p.A. intends to make acquisitions in the United States. Ugo Di Francesco, Chief Executive Officer of Chiesi Farmaceutici said: "Chiesi USA, Inc. continues to be a primary focus for investment. Our team is actively working to identify and evaluate other acquisition opportunities and we intend to continue to expand our business in the United States."

Chiesi USA, Inc. Presents at BIO-Europe 2015, Nov-02-2015

Chiesi USA, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Chiesi USA, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at